Technical advances in proteomics: new developments in data-independent acquisition

Abstract

The ultimate aim of proteomics is to fully identify and quantify the entire complement of proteins and post-translational modifications in biological samples of interest. For the last 15 years, liquid chromatography-tandem mass spectrometry (LC-MS/MS) in data-dependent acquisition (DDA) mode has been the standard for proteomics when sampling breadth and discovery were the main objectives; multiple reaction monitoring (MRM) LC-MS/MS has been the standard for targeted proteomics when precise quantification, reproducibility, and validation were the main objectives. Recently, improvements in mass spectrometer design and bioinformatics algorithms have resulted in the rediscovery and development of another sampling method: data-independent acquisition (DIA). DIA comprehensively and repeatedly samples every peptide in a protein digest, producing a complex set of mass spectra that is difficult to interpret without external spectral libraries. Currently, DIA approaches the identification breadth of DDA while achieving the reproducible quantification characteristic of MRM or its newest version, parallel reaction monitoring (PRM). In comparative de novo identification and quantification studies in human cell lysates, DIA identified up to 89% of the proteins detected in a comparable DDA experiment while providing reproducible quantification of over 85% of them. DIA analysis aided by spectral libraries derived from prior DIA experiments or auxiliary DDA data produces identification and quantification as reproducible and precise as that achieved by MRM/PRM, except on low‑abundance peptides that are obscured by stronger signals. DIA is still a work in progress toward the goal of sensitive, reproducible, and precise quantification without external spectral libraries. New software tools applied to DIA analysis have to deal with deconvolution of complex spectra as well as proper filtering of false positives and false negatives. However, the future outlook is positive, and various researchers are working on novel bioinformatics techniques to address these issues and increase the reproducibility, fidelity, and identification breadth of DIA.

Comparison of data acquisition modes with Orbitrap high‐resolution mass spectrometry for targeted and non‐targeted residue screening in aquacultured eel

“…Collecting product ion (MS2) data is important in residue analyses to characterize and confirm the identity of possible contaminants . Others have evaluated the different types of MS2 data acquisition modes available on an Orbitrap, especially for proteomic analyses . The application of HRMS screening to chemical contaminants in foods presents unique challenges.…”

Ion Mobility‐Enhanced Data‐Independent Acquisitions Enable a Deep Proteomic Landscape of Oligodendrocytes

“…DIA approaches, like MS E , PACIFIC, and SWATH, have been developed and revised in literature . Ion mobility separation (IMS) was recently combined to the MS E approach and is referred to as high‐definition MS E (HDMS E ).…”

Proteomic Response of Human Umbilical Vein Endothelial Cells to Histamine Stimulation

“…The reason for such discrepancies can be the higher precision and sensitivity of targeted MS methods or the use of only one peptide (e.g. for GPC1) in PRM–MS . Muqaku et al.…”